Biomarkers
Immunic’s MS drug shows positive biomarker results in phase 2 trial, boosting investor confidence
Anika Sharma
Immunic Therapeutics’ strategic decision to refocus its efforts earlier this year appears to be yielding positive results, drawing favorable reactions ...
Multiple Myeloma: What You Need to Know About the Latest Advances
SG Tylor
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible for producing antibodies that help ...
